BioCryst Pharmaceuticals announced that the European Medicines Agency (EMA) has approved Alpivab (peramivir), a single intravenous (I.V.) infusion for the...
The Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for...